Found: 12
Select item for more details and to access through your institution.
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0185332
- By:
- Publication type:
- Article
Cancer screening programs in South-east Asia and Western Pacific.
- Published in:
- BMC Health Services Research, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12913-023-10327-8
- By:
- Publication type:
- Article
Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0231388
- By:
- Publication type:
- Article
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0163509
- By:
- Publication type:
- Article
Development and application of a framework to estimate health care costs in China: The cervical cancer example.
- Published in:
- PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0222760
- By:
- Publication type:
- Article
A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.82818
- By:
- Publication type:
- Article
The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 12, p. 1997, doi. 10.1002/ijc.33759
- By:
- Publication type:
- Article
Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 2, p. 297, doi. 10.1002/ijc.33533
- By:
- Publication type:
- Article
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 12, p. 2410, doi. 10.1002/ijc.30926
- By:
- Publication type:
- Article
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 12, p. 2771, doi. 10.1002/ijc.30392
- By:
- Publication type:
- Article